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ARTICLE
The E3 ubiquitin ligase Pellino2 mediates priming of
the NLRP3 inﬂammasome
Fiachra Humphries1, Ronan Bergin1, Ruaidhri Jackson1, Nezira Delagic1, Bingwei Wang1, Shuo Yang1,2,
Alice V. Dubois3, Rebecca J. Ingram3 & Paul N. Moynagh1,3
The NLRP3 inﬂammasome has an important function in inﬂammation by promoting the
processing of pro-IL-1β and pro-IL-18 to their mature bioactive forms, and by inducing cell
death via pyroptosis. Here we show a critical function of the E3 ubiquitin ligase Pellino2 in
facilitating activation of the NLRP3 inﬂammasome. Pellino2-deﬁcient mice and myeloid cells
have impaired activation of NLRP3 in response to toll-like receptor priming, NLRP3 stimuli
and bacterial challenge. These functions of Pellino2 in the NLRP3 pathway are dependent on
Pellino2 FHA and RING-like domains, with Pellino2 promoting the ubiquitination of NLRP3
during the priming phase of activation. We also identify a negative function of IRAK1 in the
NLRP3 inﬂammasome, and describe a counter-regulatory relationship between IRAK1 and
Pellino2. Our ﬁndings reveal a Pellino2-mediated regulatory signaling system that controls
activation of the NLRP3 inﬂammasome.
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Pattern recognition receptors (PRR) are utilized by the innateimmune system to recognize pathogen-associated mole-cular patterns (PAMP) and trigger the induction of pro-
inﬂammatory cytokines that will promote pathogen killing and
removal from the host1. Transmembrane Toll-like receptors
(TLR) and cytosolic nucleotide-binding and oligomerization
domain (NOD)-like receptors (NLR) are important families of
PRRs2. TLRs have a cytoplasmic Toll/interleukin-1(IL-1) receptor
(TIR) domain and most TLRs, upon ligand engagement, interact
with the intracellular TIR domain-containing adapter myeloid
differentiation primary response protein 88 (MyD88)3. The latter
recruits and activates IL-1R-associated kinase 4 (IRAK4) that in
turn associates with IRAK1 to promote its
hyperphosphorylation4, 5. IRAK1 subsequently interacts with the
E3 ubiquitin ligase TNF receptor-associated factor 6 (TRAF6) and
TAK1 kinase that activates the IkappaB (IκB) kinase (IKK)
complex to phosphorylate and promote proteasomal degradation
of IκB proteins, key inhibitors of the NFκB transcription factor6.
This allows for nuclear translocation of NFκB. TAK1 also triggers
downstream activation of the p38, ERK, and JNK MAP kinase
(MAPK) pathways that co-operate with NFκB to regulate the
transcription of a plethora of pro-inﬂammatory genes including
those encoding TNF, IL-1β, IL-18, and IL-67. The inﬂammatory
cytokines IL-1β and IL-18 are initially produced as inactive pre-
cursor proteins and require the generation of a signaling platform
termed the inﬂammasome that processes IL-1β and IL-18 into
their mature bioactive forms before being released from cells8–10.
Thus, the secretion of mature IL-1β requires two signals. Firstly
innate receptors, such as TLR4, is engaged by its ligand lipopo-
lysaccharide (LPS) in Gram negative bacteria, to activate NFκB
and induce transcription of the gene encoding the inactive pro-
IL-1β precursor11 with a second signal triggering inﬂammasome
activation. Inﬂammasomes consist of a NLR protein such as
NLRP3 that recruits the adapter protein ASC and caspase-1 into
an oligomeric complex leading to auto-proteolytic processing of
pro-caspase-1 into its active form that cleaves pro-IL-1β and pro-
IL-18 precursors into their mature secreted forms12, 13. The
activation of the inﬂammasome can also lead to a necrotic form
of cell death termed pyroptosis14. The activators of NLRP3
include ATP, PAMPs, danger associated molecular patterns
(DAMPs), and particulate substances. Additional NLR proteins,
such as NLRC4, that is activated via NLR family apoptosis
inhibitory proteins (NAIPs) and bacterial ﬂagellin, can also form
inﬂammasome complexes15, 16. Other inﬂammasome complexes
include the cytosolic DNA sensor Absent in Melanoma-2 (AIM2)
that associates with ASC and triggers inﬂammasome activation17.
These canonical inﬂammasome pathways are also complemented
by a non-canonical inﬂammasome in which murine caspase-11
(caspase-4 and caspase-5 in human cells) directly binds to cyto-
solic LPS18 and is activated to induce pyroptosis in an analogous
manner to caspase-119, 20. While caspase-4, caspase-5, and
caspase-11 cannot cleave pro-IL-1β or pro-IL-18, these caspases
can promote the assembly of the NLRP3 inﬂammasome19, 21, 22 to
indirectly induce the production and secretion of the mature
forms of IL-1β and IL-18.
There is much interest in delineating the molecular mechanisms
that regulate inﬂammasome activation23. A number of ﬁndings
have shown the signiﬁcance of post-translational modiﬁcation of
components of the inﬂammasome with ubiquitination being of
particular importance. TRIM31, FBXL2, and MARCH7 have been
reported to promote ubiquitination and degradation of NLRP324–26
with NLRP3 needing to be de-ubiquitinated by the BRCC3 complex
in order to facilitate NLRP3 activation27–29. However, there are
currently no reports on E3 ubiquitin ligases directly contributing to
activation of NLRP3. Here we show a critical role for the E3
ubiquitin ligase Pellino2 in regulating activation of the NLRP3
pathway.
Pellino proteins constitute a three-membered family of E3
ubiquitin ligases that have various regulatory roles in innate
immune signaling pathways3, 30, 31. Originally identiﬁed as IRAK-
interacting proteins, each family member shares an N-terminal
forkhead-associated (FHA) domain that recognizes phospho-
threonine residues and mediates association with IRAK132, and a
C-terminal RING-like domain that confers E3 ubiquitin ligase
activity and an ability to catalyze lysine 63 (K63)-linked poly-
ubiquitination of substrate proteins such as IRAKs33–35. Pellino
proteins are subject to phosphorylation by kinases, such as IRAK1
and TBK1/IKKε, that can enhance the E3 ligase activities of the
Pellino proteins35–39. Murine genetic models have revealed roles
for Pellino1 in TLR3 and TLR4 signaling pathways40, as a sup-
pressor of T cell activation41, 42, a driver of neuroinﬂammation43,
and as a promoter of lymphomagenesis44 and lung carcinogen-
esis45. We have previously generated Pellino3-deﬁcient mice to
identify important roles for Pellino3 as a negative regulator of
TLR3 signaling46 and TNF-induced cell killing47, a mediator of
NOD2 signaling in the gut48 and a critical regulator of obesity-
induced expression of IL-1β and insulin resistance49.
While progress has been made in elucidating the functions of
Pellino1 and Pellino3, there is a notable lack of insight into the
physiological roles of Pellino2. Studies on Pellino2 have been
largely conﬁned to overexpression and knockdown approaches in
cell lines that suggest a role for Pellino2 in IL-1/LPS-induced
activation of ERK and JNK MAPK pathways and increased sta-
bilization of mRNAs encoding pro-inﬂammatory proteins50, 51.
We now generate Pellino2-deﬁcient mice to reveal the ﬁrst phy-
siological role of Pellino2 as a mediator in the activation of the
NLRP3 inﬂammasome pathway. We show that Pellino2 facilitates
NLRP3-induced maturation and release of IL-1β and IL-18 in
macrophages, while also promoting cell death by pyroptosis. The
pathophysiological relevance of this role for Pellino2 is also
shown by its contribution to the lethal effects of LPS in a murine
model of endotoxemia and the in vivo induction of IL-1β in
response to challenge with Gram negative bacteria. Pellino2 exerts
its positive effects by promoting ubiquitination of NLRP3. We
also identify for the ﬁrst time that IRAK1 acts as an inhibitor of
the NLRP3 pathway and reveal a counter-regulatory relationship
between Pellino2 and IRAK1. In addition to revealing the ﬁrst
physiological role for Pellino2, this study also maps an entirely
new regulatory pathway that controls NLRP3 activation.
Results
Pellino2 mediates mature IL-1β production in response to LPS.
In order to explore the physiological role for Pellino2 we gener-
ated Pellino2-deﬁcient mice. Homologous recombination was
used in embryonic stem cells to replace exons 2 to 6 in the Peli2
gene with an F3-ﬂanked selection cassette (Supplementary
Fig. 1a). The selection cassette was subsequently removed by
crossing mice with this targeted allele to mice expressing a Flp
transgene thus generating mice with deletions of exons 2 to 6 of
the Peli2 gene, as conﬁrmed by PCR analysis (Supplementary
Fig. 1b). Semi-quantitative (Supplementary Fig. 1c) and real-time
(Supplementary Fig. 1d) RT-PCR analysis of mRNA, isolated
from bone marrow-derived macrophages (BMDMs), conﬁrmed
complete lack of expression of the Peli2 gene in cells from Peli2
−/− mice. Pellino2-deﬁcient mice are viable and develop nor-
mally. Given the previously described roles for Pellino1 and
Pellino3 in TLR signaling pathways, we initially compared the
responsiveness of BMDMs from wild type (WT) and Pellino2-
deﬁcient mice to 24 h challenge with a wide array of TLR ligands,
as measured by induction of the TLR-responsive proteins IL-6
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(Fig. 1a), CXCL1 (Fig. 1b), TNF (Fig. 1c), RANTES (Fig.1d), and
IFN-β (Fig. 1e). Each TLR ligand retained its ability to induce all
of these cytokines in BMDMs lacking Pellino2 indicating its lack
of physiological participation in these TLR signaling pathways.
Since we have previously identiﬁed Pellino3 as an inhibitor of IL-
1β expression, we next explored the role of Pellino2 in controlling
the production of IL-1β. The levels of secreted IL-1β protein, in
response to LPS, were strongly reduced in Pellino2-deﬁcient
BMDMs (Fig. 1f), suggesting a selective role for Pellino2 in the
pathway controlling the production of IL-1β but not other pro-
inﬂammatory proteins. However, Pellino2 is not involved in the
transcriptional regulation of Il1b gene since LPS-induced
expression of Il1b mRNA (Supplementary Fig. 2a) and pro-IL-
1β protein (Supplementary Fig. 2b) is fully intact in Pellino2-
deﬁcient BMDMs. Indeed Pellino2 is dispensable for the early
intracellular signaling pathways triggered by LPS that drive
expression of the Il1b gene, since WT and Peli2−/− BMDMs
displayed the same patterns of time-dependent activation of
NFκB and MAPK pathways as measured by phosphorylation of
IκBα, p38 MAPK, JNK, and ERK (Supplementary Fig. 2c).
Pellino2 mediates LPS-induced activation of NLRP3. Given
that Pellino2 is not required for induction of pro-IL-1β we next
probed the role of Pellino2 in the activation of inﬂammasomes.
We initially employed the widely used two-signal model of LPS
and ATP to evaluate the involvement of Pellino2 in the NLRP3
pathway. The priming of BMDMs from WT mice with LPS fol-
lowed by stimulation with ATP resulted in strong expression and
secretion of mature IL-1β, as measured by ELISA. However, this
response was considerably reduced in cells from Peli2−/− mice
(Fig. 2a). Pellino2-deﬁcient cells also exhibited reduced levels of
IL-18 (Fig. 2b) and pyroptosis (Fig. 2c) relative to WT BMDMs,
suggesting that Pellino2 plays a vital role in the NLRP3 pathway.
This was further supported with immunoblotting analysis that
demonstrated Peli2−/− BMDMs to be less responsive than
WT cells to LPS/ATP-induced processing of pro-IL-1β into its
mature p17 IL-1β form and pro-caspase-1 into its active p20 form
(Fig. 2d). β-Actin was used as a loading control in all immuno-
blotting analysis since its electrophoretic mobility is mid-range of
the various proteins subjected to immunoblotting. Levels of
processed IL-1β and caspase-1 were comparable between WT and
Peli2−/− BMDMs in response to double stranded DNA (poly
(dA:dT), a trigger of the AIM2 inﬂammasome, suggesting some
speciﬁcity for the NLRP3 pathway. To further conﬁrm the role of
Pellino2 in the NLRP3 pathway, another two-signal model,
involving LPS as a prime stimulus followed by the potassium
ionophore nigericin, was employed as an alternative approach to
activate the NLRP3 pathway. Again Peli2−/− BMDMs were much
less responsive than WT cells with respect to LPS/nigericin-
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Fig. 1 Pellino2 is required for production of IL-1β in response to LPS. a-e Enzyme-linked immunosorbent assay (ELISA) of a IL-6, b CXCL1, c TNF, d RANTES,
and e IFN-β expression in medium from BMDMs isolated from wild-type (WT) and Pellino2-deﬁcient (Peli2−/−) mice and treated with 10 ng/ml Pam2CSK,
10 ng/ml Pam3CSK, 1 μg/ml Zymosan, 25 μg/ml poly(I:C), 100 ng/ml lipopolysaccharide (LPS), 1 μg/ml ﬂagellin, 1 μg/ml Clo75, 1 μg/ml Clo97, and 2 μg/
ml CpG for 24 h. UT, untreated. f ELISA of IL-1β in medium fromWT and Peli2−/− BMDMs stimulated with the indicated concentrations of LPS for 24 h. *p
< 0.05 (paired, two-tailed Student’s t-test). Data are presented as the mean of three independent experiments (a-f). Error bars, s.e.m.
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induced production of mature IL-1β (Fig. 2e), IL-18 (Fig. 2f),
pyroptosis (Fig. 2g), and processing of pro-IL-1β and pro-
caspase-1 (Fig. 2h). While ATP and nigericin promotes NLRP3
activation by facilitating potassium efﬂux, particulate material like
alum can also activate NLRP3. We next demonstrated that
Pellino2 is also required for alum-mediated secretion of IL-1β
(Fig. 2i). These data are all consistent with a role for Pellino2 in
activation of the NLRP3 pathway. In keeping with its potential
targeting of NLRP3, the role of Pellino2 is independent on the
priming stimulus. Using the TLR2 ligand zymosan, as an
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alternative ﬁrst signal with ATP, resulted in comparable levels of
zymosan-induced expression of Il1b mRNA (Supplementary
Fig. 3a) and pro-IL-1β protein (Supplementary Fig. 3b) in WT
and Peli2−/− cells. However, processing of pro-IL-1β (Supple-
mentary Fig. 3c) and secretion of mature IL-1β (Supplementary
Fig. 3d) in Peli2−/− BMDMs was severely impaired.
Having demonstrated a role for Pellino2 in the NLRP3
pathway in macrophages derived from bone marrow we wished
to conﬁrm a similar role in naturally occurring tissue resident
macrophages. Peritoneal macrophages from Peli2−/− mice had
less LPS/ATP induction of mature IL-1β than corresponding
WT cells (Fig. 2j). Furthermore, we also conﬁrm a role for
Pellino2 in the NLRP3 pathway in human cells by showing that
knockdown of PELI2 expression in the human monocytic THP1
cell line (Fig. 2k) reduced LPS-, LPS/ATP-, and LPS/nigericin-
induced secretion of mature IL-1β (Fig. 2l) and this is consistent
with less processing of IL-1β and caspase-1 in PELI2 knockdown
cells (Fig. 2m).
We further examined the speciﬁcity of the role of Pellino2 for
the NLRP3 inﬂammasome. Pellino2 is not employed in other
canonical inﬂammasome pathways such as NLRC4 and
AIM2 since respective triggers of these inﬂammasomes, ﬂagellin
and poly (dA:dT), had comparable efﬁcacy in inducing IL-1β in
WT and Peli2−/− BMDMs (Supplementary Fig. 4a). Further-
more, Pellino2 was dispensable for non-canonical inﬂammasome
activation as Pellino2 deﬁciency did not affect the ability of
cytosolic LPS to trigger processing of mature IL-1β (Supplemen-
tary Fig. 4b) or pyroptosis (Supplementary Fig. 4c). Additionally,
cholera toxin B (CTB) co-administration with LPS provides
another way to activate the non-canonical inﬂammasome19.
Again LPS/CTB-induced release of mature IL-1β (Supplementary
Fig. 4d) and pyroptosis (Supplementary Fig. 4e) were unaltered in
BMDMs lacking Pellino2. Together, these data suggest that
Pellino2 is not involved in non-canonical inﬂammasome
activation and instead serves a selective role in the canonical
NLRP3 pathway.
Pellino2 contributes to LPS-induced lethality. We next aimed to
explore the physiological relevance of the role for Pellino2 in
responding to LPS by extending our studies into in vivo models.
Consequently, WT and Peli2−/− mice were subjected to intra-
peritoneal administration of non-lethal dose of LPS and serum
levels of a range of cytokines were assayed. LPS-induced increased
serum levels of IL-6 (Fig. 3a), TNF (Fig. 3b), CXCL1 (Fig. 3c),
RANTES (Fig. 3d), and IL-1β (Fig. 3e) in WT mice and whereas
the same levels of IL-6, TNF, CXCL1, and RANTES were
observed in Pellino2-deﬁcient mice, the serum levels of IL-1β in
Peli2−/− mice were reduced relative to WT mice (Fig. 3e). These
data are consistent with our earlier ﬁndings above that indicated a
role for Pellino2 in controlling IL-1β maturation. The
pathophysiological relevance of this role was further evaluated by
administering mice with lethal dose of LPS and survival mon-
itored over a 72 h period post administration. All WT mice
succumbed to the lethal effects of LPS after 48 h but Peli2−/−
mice had a 50% survival rate up to 72 h (Fig. 3f) suggesting that
Pellino2 plays an important in vivo role in mediating IL-1β
production in response to LPS and in promoting LPS-induced
lethality in endotoxaemia.
Pellino2 mediates NLRP3 anti-bacterial responses. We exten-
ded our studies on the physiological relevance of the role of
Pellino2 in responding to LPS and in promoting inﬂammasome
activation by comparing the responsiveness of BMDMs from WT
and Peli2−/− mice to the Gram negative bacteria Citrobacter
rodentium (C. rodentium) and Escherichia coli (E. coli). Although
these bacteria activate the NLRP3 inﬂammasome they can also
induce caspase-11 expression and synergize with activated
NLRP3 to process IL-1 family cytokines and instigate
pyroptosis52, 53. C. rodentium induced production of mature IL-
1β (Fig. 4a) and caspase-11 (Fig. 4b) in WT BMDMs and whereas
the levels of IL-1β were reduced in Peli2−/− cells, the expression
of caspase-11 was intact. Similarly, E.coli induced IL-1β
maturation in a Pellino2-dependent manner (Fig. 4c) whereas
caspase-11 expression was independent of Pellino2 (Fig. 4d)
suggesting a direct and speciﬁc role for Pellino2 in the NLRP3
pathway. Pellino2 also mediated the production of IL-1β and IL-
18 but not CXCL1 (Fig. 4e) and processing of pro-caspase-1
(Fig. 4f) in response to another Gram negative bacteria Pseudo-
monas aeruginosa (P. aeruginosa). This again supports a role for
Pellino2 in bacterial-induced inﬂammasome activation. The
physiological relevance of this role was conﬁrmed by demon-
strating that P. aeruginosa-infected Peli2−/− mice produced less
IL-1β and IL-18 but the same levels of another pro-inﬂammatory
cytokine IL-6 compared with infected WT mice (Fig. 4g).
Pellino2 FHA and RING domains facilitate NLRP3 activation.
Having provided strong supporting evidence for a role for Pel-
lino2 in the NLRP3 inﬂammasome, we next probed the under-
lying mechanism. Our initial mechanistic studies focused on
Pellino2 itself and the functional relevance of its FHA and RING-
like domains for NLRP3 activation. To this end, we used murine
stem cell virus (MSCV) transduction to re-constitute Peli2−/−
BMDMs with WT murine Pellino2 and mutated forms with point
mutations in its FHA or RING-like domain (Fig. 5a). The re-
introduction of WT murine Pellino2 into Peli2−/− BMDMs
reconstituted the ability of LPS/ATP to induce IL-1β and IL-18 to
levels that were equivalent to those observed in WT BMDMs
(Fig. 5b). However, the FHA mutant form of Pellino2, that lacks
substrate binding activity, and the RING mutant form, that lacks
E3 ubiquitin ligase activity, failed to re-constitute LPS/ATP
Fig. 2 Pellino2 mediates activation of the NLRP3 pathway. ELISA of a IL-1β and b IL-18, and c LDH assay of medium fromWT and Peli2−/− BMDMs treated
with 100 ng/ml LPS for 3 h with or without further stimulation with 2.5 mM ATP for 1 h. UT, untreated. d Immunoblot analysis of IL-1β and Caspase-1 in
medium (Sup) and lysates from WT and Peli2−/− BMDMs stimulated with 100 ng/ml LPS for 3 h with or without further stimulation with 2.5 mM ATP for
1 h or transfection of Poly (dA:dT) (1 μg/ml) for 6 h. ELISA of e IL-1β and f IL-18 and g LDH assay of medium from WT and Peli2−/− BMDMs treated with
100 ng/ml LPS for 3 h with or without further stimulation with 5mM Nigericin for 1 h. h Immunoblot analysis of IL-1β and Caspase-1 in medium (Sup) and
lysates from WT and Peli2−/− BMDMs stimulated with 100 ng/ml LPS for 3 h with or without further stimulation with 5mM Nigericin for 1 h or
transfection of Poly (dA:dT) (1 μg/ml) for 6 h. i ELISA of IL-1β of medium from WT and Peli2−/− BMDMs treated with 100 ng/ml LPS for 3 h with or
without further stimulation with the indicated concentrations of Alum for 6 h. j ELISA of IL-1β in medium from peritoneal-resident macrophages isolated
from WT and Peli2−/− mice. Cells were treated with 100 ng/ml of LPS for 3 h with or without further stimulation with 2.5 mM ATP for 1 h. k-m Human
THP1 cells were transfected with human Pellino2-speciﬁc siRNA or control siRNA. k Quantitative RT-PCR analysis of PELI2 expression in transfected cells. l
ELISA of IL-1β in medium from transfected THP1 cells stimulated with 100 ng/ml LPS for 6 h with or without further treatment with 2.5 mM ATP or 5mM
Nigericin for 1 h.m Immunoblot analysis of IL-1β and Caspase-1 in medium (Sup) and lysates from transfected THP1 cells stimulated with 100 ng/ml LPS for
6 h with or without further stimulation with 2.5 mM ATP or 5 mM Nigericin for 1 h. β-Actin was used as loading controls. *p < 0.05 (paired, two-tailed
Student’s t-test). Data are biological replicates that are representative of three independent experiments. Error bars, s.e.m.
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function in Peli2−/− BMDMs. These data indicate that Pellino2 is
dependent on both its FHA and RING-like domains in order to
trigger activation of the NLRP3 pathway. This is further sup-
ported by the observation that the re-introduction of WT Pellino2
could re-constitute the LPS/ATP-induced processing of pro-
caspase-1 in Peli2−/− BMDMs to the same degree as displayed in
WT cells whereas both the FHA and RING-like mutants of Pel-
lino2 were ineffective in this regard (Figs. 5c, d).
Pellino2 is required for NLRP3-induced ASC oligomerization.
We next aimed to explore how Pellino2 can integrate into the
NLRP3 pathway. The production of mROS has been proposed as
a general converging mechanism for various NLRP3 stimuli.
However, WT and Peli2−/− BMDMs produced the same levels of
mitochondrial ROS under conditions of NLRP3 activation with
LPS and ATP (Supplementary Fig. 5). This suggested that Pel-
lino2 acts independently of such a general triggering mechanism
and so we focused on more speciﬁc protein targets in the NLRP3
pathway. Given the crucial role of ASC in the NLRP3
inﬂammasome and since the assembly of the NLRP3 inﬂamma-
some is associated with oligomerization of ASC, that manifests as
a single ASC speck in cells, we next characterized the effects of
Pellino2 deﬁciency on ASC aggregation under conditions of
NLRP3 activation. ASC speck formation was detectable in WT
BMDMs that were primed with LPS and then stimulated with
ATP but the number of cells displaying ASC formation under
these conditions was signiﬁcantly reduced in Peli2−/− BMDMs
(Fig. 6a). Since ASC speck formation reﬂects oligomerization of
ASC, we treated cell lysates with a bifunctional chemical cross-
linking agent and subjected samples to ASC immunoblotting to
assess for oligomerization. LPS/ATP-induced strong oligomer-
ization of ASC in WT BMDMs but the levels of higher molecular
weight ASC oligomers were reduced in Peli2−/− BMDMs
(Fig. 6b), in keeping with impaired ASC speck formation under
the same conditions. To further conﬁrm the role of Pellino2 in
mediating NLRP3-induced ASC aggregation, we used LPS/
nigericin as a second means to activate the NLRP3 inﬂamma-
some. LPS priming, followed by nigericin stimulation, promoted
ASC oligomerization in WT BMDMs but this was again reduced
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in Peli2−/− BMDMs (Fig. 6c) consistent with Pellino2 facilitating
ASC oligomerization in response to NLRP3 activation. The
impaired NLRP3-induced oligomerization of ASC in Peli2−/−
BMDMs was overcome by re-constituting these cells with WT
Pellino2 (Fig. 6d). However, mutated forms of Pellino2 with point
mutations in its FHA or RING-like domains failed to re-
constitute this function of Pellino2. This correlates closely with
the earlier re-constitution of NLRP3-induced IL-1β and IL-18
expression with WT Pellino2 but not mutated forms (Fig. 5b)
strongly indicating that Pellino2-mediated ASC oligomerization
translates into downstream production of mature bioactive forms
of IL-1β and IL-18.
Pellino2 promotes ubiquitination of NLRP3. Given that Pel-
lino2 appears to act upstream of ASC, we next investigated
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NLRP3 as a potential direct target for Pellino2. We were espe-
cially interested in characterizing the regulatory mechanisms
controlling ubiquitination of NLRP3 since earlier studies had
shown NLRP3 to be subject to ubiquitination and our data above
indicated the mediatory role of Pellino2 to be dependent on the
RING-like domain that underpins its E3 ubiquitin ligase activity.
We thus treated WT and Peli2−/− BMDMs with LPS for various
times, immunoprecipitated NLRP3 and analyzed the ubiquitina-
tion status by Western blotting. LPS promoted time-dependent
polyubiquitination of NLRP3 in WT cells and this was con-
siderably reduced in Peli2−/− BMDMs (Fig. 7a) indicating that
LPS induces ubiquitination of NLRP3 in a Pellino2-dependent
manner. We next deﬁned the type of linkages in the polyubiquitin
chains that are attached to NLRP3. Thus, using K63-speciﬁc
TUBEs we isolated K63-linked ubiquitinated proteins followed by
immunoblotting for NLRP3 to show that LPS promotes time
dependent K63-linked ubiquitination of NLRP3 in WT macro-
phages and this is reduced in Pellino2-deﬁcient cells (Fig. 7b).
Similar approaches using K48-speciﬁc TUBEs failed to detect any
K48-linked ubiquitination of NLRP3 in response to LPS (Fig. 7c)
demonstrating that LPS promotes K63-linked ubiquitination of
NLRP3 in a Pellino2-dependent manner. While previous reports
have described a requirement for NLRP3 to be de-ubiquitinated
in order to trigger downstream effects of inﬂammasome activa-
tion, our data lead us to hypothesize that part of the priming for
NLRP3 inﬂammasome activation by LPS may be related to a
requirement to initially induce ubiquitination of NLRP3. We
present further evidence in support of this hypothesis by
demonstrating that MCC950, a highly selective inhibitor of
NLRP354, strongly suppresses LPS/ATP induction of IL-1β in
WT BMDMs (Fig. 7d) and also inhibits LPS-induced ubiquiti-
nation of NLRP3 (Fig. 7e). Interestingly, while MCC950 strongly
suppressed the ability of LPS to promote ubiquitination of
NLRP3, MCC950 also appeared to cause some basal ubiquitina-
tion of NLRP3 in unstimulated cells. In order to address these
apparent contrasting roles of MCC950 we characterized the
effects of MCC950 on formation of polyubiquitin chains of dif-
ferent linkages. Using K63-speciﬁc TUBEs to isolate K63-linked
ubiquitinated proteins we revealed LPS-induced K63-linked ubi-
quitination of NLRP3 and this was fully abrogated in cells pre-
treated with MCC950 (Fig. 7f). Notably, MCC950 alone failed to
induce any K63-linked ubiquitination of NLRP3 suggesting that
the basal ubiquitination of NLRP3 observed in response to
MCC950 (Fig. 7e) is due to ubiquitin chains that are joined by
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d
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different linkages. Thus, LPS promotes transient K63-linked
ubiquitination of NLRP3, that may prime NLRP3 for subsequent
activation and this is countered by the inhibitory effects of
MCC950 that oppose the K63-linked ubiquitination of NLRP3.
These data arising from the use of MCC950 are consistent with
our hypothesis of a requirement for LPS to prime K63-linked
ubiquitination of NLRP3 for its later activation and suggests that
impaired ubiquitination of NLRP3 in response to LPS in Peli2−/−
BMDMs may underlie the reduced activation of NLRP3 in these
cells. Indeed MCC950 does not affect the residual LPS/ATP-
induced levels of IL-1β in Peli2–/– BMDMs (Fig. 7d) raising the
possibility that the targeting of NLRP3 ubiquitination may con-
tribute to the inhibitory effects of MCC950.
We next characterized the nature of the functional relationship
between Pellino2 and NLRP3. Using Peli2−/− BMDMs, recon-
stituted with a myc-tagged form of Pellino2 that we described
above to restore NLRP3 activation, we demonstrated that LPS
induces a time-dependent interaction of Pellino2 with NLRP3
(Fig. 7g). We assessed the potential of Pellino2 to act as a direct
E3 ligase for NLRP3. However, the co-expression of Pellino2 and
NLRP3 with WT ubiquitin (Supplementary Fig. 6a) or a mutant
ubiquitin form containing a single lysine at residue 63 (K63A)
(Supplementary Fig. 6b) failed to show any Pellino2-induced
ubiquitination of NLRP3. This suggested that Pellino2 may be
exerting its effects on NLRP3 in a more indirect manner and
possibly, by targeting a protein that directly regulates NLRP3.
IRAK1 inhibits NLRP3 and is targeted by Pellino2. Given that
we have previously shown Pellino2 to interact with IRAK1 and the
latter can associate with NLRP3 we investigated the ability of
Pellino2 to target IRAK1 and regulate its binding to NLRP3. In
keeping with previous studies we show that Pellino2 can interact
with IRAK1 (Fig. 8a) and promote ubiquitination of IRAK1 in a
RING domain-dependent manner (Fig. 8b) when these proteins
are co-expressed in HEK293T cells. LPS also induced time-
dependent ubiquitination of IRAK1 in WT BMDMs and this was
suppressed in Peli2−/− cells (Fig. 8c) highlighting Pellino2 as an
important mediator of IRAK1 ubiquitination in response to LPS.
While such ubiquitination by LPS in WT cells is followed by
degradation of most of the pool of IRAK1, the greatly reduced
ubiquitination of IRAK1 in Peli2−/− cells still permitted degra-
dation of IRAK1, albeit with slightly delayed kinetics and more
residual IRAK1 than in WT cells. Furthermore, using TUBEs to
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isolate ubiquitinated proteins we again demonstrated that LPS-
induced ubiquitination of IRAK1 was reduced in Peli2−/− cells
(Fig. 8d). We next assessed the effects of the loss of IRAK1 ubi-
quitination in Peli2−/– cells on the ability of IRAK1 to interact
with NLRP3. LPS promoted time-dependent interaction of IRAK1
with NLRP3 in WT BMDMs but this interaction was augmented
in Peli2−/− cells (Fig. 8e) suggesting that Pellino2-mediated ubi-
quitination of IRAK1 may impair the binding of the latter to
NLRP3. We were thus keen to study the functional relevance of
IRAK1 binding to NLRP3 and compared NLRP3 activation
between WT and IRAK1-deﬁcient BMDMs. Intriguingly the
absence of IRAK1 resulted in further enhancement of the levels of
mature IL-1β produced in response to LPS/ATP or LPS/nigericin
(Fig. 8f, left panel), two regimes to trigger the NLRP3 inﬂamma-
some. In contrast, the absence of IRAK1 leads to reduced levels of
TNF (Fig. 8f, right panel) in keeping with the early receptor
proximal role of IRAK1 in the TLR4 pathway that drives induc-
tion of TNF55. Τhis suggests that IRAK1 acts to negatively regulate
NLRP3 and this was further supported by augmented processing
of pro-IL-1β and pro-caspase-1 in IRAK1-deﬁcient BMDMs
(Fig. 8g). Similar ﬁndings were also observed in IRAK1-deﬁcient
immortalized BMDMs (Supplementary Fig. 7a, b) with these
studies also including control experiments with IRAK4-deﬁcient
cells that produced barely detectable levels of secreted IL-1β
(Supplementary Fig. 7a). The latter is likely due to IRAK4 being an
essential mediator of the LPS priming of pro-IL-1β production.
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We next investigated if IRAK1 could regulate the ubiquitination of
NLRP3 since IRAK1 is dispensable for signal 1-mediated induc-
tion of pro-IL-1β. We initially co-expressed IRAK1 and NLRP3
and while it proved difﬁcult to detect any ubiquitination of NLRP3
when expressed alone or with IRAK1, intense ubiquitination of
NLRP3 was observed when co-expressed with a kinase dead form
of IRAK1 (Fig. 8h). Since the latter likely acts as a dominant
negative inhibitor of endogenous IRAK1, the study suggested that
the kinase activity of IRAK1 may act to suppress NLRP3 ubi-
quitination. We also compared LPS-induced ubiquitination of
NLRP3 in WT and IRAK1-deﬁcient BMDMs and observed
enhanced NLRP3 ubiquitination in the absence of IRAK1 (Fig. 8i).
Intriguingly the enhanced ubiquitination of NLRP3 in IRAK1-
deﬁcient cells is also associated with increased binding of Pellino2
to NLRP3 (Fig. 8j) again supporting a role for Pellino2-dependent
ubiquitination of NLRP3 being an important part of LPS priming
of the NLRP3 inﬂammasome. These data are consistent with a
model of NLRP3 activation that is counter-regulated by IRAK1
and Pellino2 (Fig. 9). Thus, we propose that IRAK1 binds to
NLRP3 to suppress ubiquitination and priming of NLRP3. Pel-
lino2 can counter this braking mechanism with these effects of
Pellino2 being associated with facilitation of IRAK1 ubiquitina-
tion, dissociation of IRAK1 from NLRP3 and ubiquitination of
NLRP3 in a Pellino2-dependent manner. While over-expression
studies have previously shown Pellino2 to promote ubiquitination
of IRAK135, in vitro ubiquitination assays with puriﬁed forms of
Pellino2 and IRAK would be required to conﬁrm that IRAK1 is a
direct substrate for Pellino2. Overall, our data demonstrate a role
for Pellino2 in the priming phase of the NLRP3 pathway that
facilitates NLRP3 inﬂammasome assembly, ASC oligomerization
and downstream caspase-1-mediated processing of pro-IL-1β and
pro-IL-18.
Discussion
This study identiﬁes the ﬁrst physiological role of Pellino2 and a
new regulatory network that controls the NLRP3 inﬂammasome.
The ﬁndings highlight an important role for Pellino2 in NLRP3
activation by promoting the K63-linked ubiquitination of NLRP3
as part of the priming phase. We also propose that IRAK1 can
negatively regulate ubiquitination of NLRP3 and its downstream
signaling and Pellino2 can counter this effect by ubiquitinating
IRAK1 thus impairing interaction of the latter with NLRP3 and
relieving the braking system of IRAK1 on the NLRP3 inﬂam-
masome. The need for such complex regulatory control of the
NLRP3 inﬂammasome is likely due to the damaging con-
sequences of unregulated NLRP3 activity in response to infection
and also in auto-inﬂammatory diseases56.
There is an emerging appreciation of the physiological roles of
Pellino proteins. Pellino1 plays important roles in TLR3 and
TLR4 pathways40, T cell activation41, CNS inﬂammation43, and
cancer generation44, 45. We have previously shown Pellino3 to
negatively regulate TLR3 signaling46, suppress TNF-induced cell
death47, regulate IL-1β expression to control obesity-induced
insulin resistance49, and mediate NOD2 signaling to facilitate gut
homeostasis48. However, until this present study, there have been
no reports on the physiological role of Pellino2. We now propose
that it plays an important mediatory role in assembly and acti-
vation of the NLRP3 inﬂammasome. Pellino2 is not involved in
TLR-induced activation of NFκB or induction of pro-IL-1β or
NLRP3 but instead facilitates the K63-linked ubiquitination of
NLRP3 and we propose this as a novel pathway in the priming
process. The lack of role of Pellino2 in the NFκB pathway and
other early signaling pathways such as MAPK cascades is con-
sistent with its absence of involvement in TLR-induced expres-
sion of pro-inﬂammatory proteins in macrophages. Interestingly
previous studies using overexpression and gene knockdown
approaches in cell lines had proposed a role for Pellino2 in
mediating LPS-induced activation of MAPK pathways to regulate
pro-inﬂammatory gene expression50, 51. However, we show that
these pathways are intact and functional in Pellino2-deﬁcient cells
suggesting that its role, if any, is dispensable in these signal
transduction pathways. This may be due to functional redun-
dancy with other E3 ubiquitin ligases and indeed a recent report
suggests some redundancy between Pellino1, Pellino2, and
TRAF6, at least with respect to IL-1 signaling57. However, the
impaired activation of NLRP3 activation in Pellino2-deﬁcient
cells clearly indicates a critical role for Pellino2 in inﬂammasome
biology that cannot be fully served by other E3 ubiquitin ligases.
Interestingly, Pellino2 joins Pellino3 as E3 ubiquitin ligases that
play important roles in NLR signaling. Pellino3 mediates activa-
tion of NOD2 to facilitate gut homeostasis48 and we now show
that Pellino2 mediates activation of NLRP3 and its inﬂammasome
complex. Furthermore, both Pellino proteins target kinases in
manifesting these effects with Pellino3 promoting ubiquitination
of RIP2 to mediate NOD2 signaling and Pellino2 targeting IRAK1
to facilitate NLRP3 inﬂammasome activation. Pellino1 also acts as
an E3 ubiquitin ligase for RIP1 in the TLR3 and TLR4 path-
ways40. The present study now conﬁrms that all Pellino family
members target and ubiquitinate key regulatory kinases in innate
immune signaling.
Our data also highlight the intriguing ability of Pellino family
members to differentially regulate the same pathway. We have
recently shown that Pellino3 can negatively regulate the expres-
sion of pro-IL-1β by destabilizing the transcription factor HIF-1α
and so suppress the transcription of the Il1b gene49. We now
Fig. 8 Pellino2 ubiquitinates IRAK1 and suppress the inhibitory effects of IRAK1 on NLRP3. a Immunoblot analysis of myc and IRAK1 in lysates (Input) and
immunoprecipitated (IP) myc samples from HEK293T cells transfected with myc-tagged Pellino2 and untagged IRAK1. b Immunoblot analysis of HA, IRAK1
and FLAG in lysates (Input) and IP IRAK1 samples from HEK293T cells transfected with FLAG-tagged Pellino2, FLAG-tagged Pellino2 RING mutant,
untagged IRAK1, and HA-Ubiquitin. c, d Immunoblot analysis of Ubiquitin (short exposure (SE) or long exposure (LE)) and IRAK1 in lysates (Input) and IP
IRAK1 samples or IRAK1 and ubq in TUBE-Ubq elution and cell lysates (d) from WT and Peli2−/− BMDMs treated with 100 ng/ml of LPS for the indicated
times. e Immunoblot analysis of NLRP3 and IRAK1 in lysates (Input) and IP IRAK1 samples from WT and Peli2−/− BMDMs treated with 100 ng/ml LPS for
the indicated times. f ELISA of IL-1β (left panel) and TNF (right panel) in medium from primary WT and Irak1−/− BMDMs treated with 100 ng/ml LPS for 3
h and then with 2.5 mM ATP or 5 mM Nigericin for 1 h. UT, untreated. g Immunoblot analysis of IL-1β and Caspase-1 in medium (Sup) and lysates of WT
and Irak1−/− BMDMs stimulated with 100 ng/ml LPS for 3 h and 2.5 mM ATP for 1 h. h Immunoblot analysis of HA, NLRP3, and IRAK1 in lysates (Input)
and IP NLRP3 samples from HEK293T cells transfected with V5-tagged NLRP3, untagged IRAK1, untagged kinase dead IRAK1 (IRAK1-KD), and HA-
ubiquitin. β-Actin was used as loading controls. i Immunoblot analysis of Ubiquitin, NLRP3, and IRAK1 in lysates (Input) and IP NLRP3 samples from
immortalized WT and Irak1−/− BMDMs treated with 100 ng/ml LPS for the indicated times. j Immortalized WT and Irak1−/− BMDMs were infected with
MSCV as control (Ctrl) or with MSCV containing an expression construct encoding myc-tagged murine Pellino2 (Peli2), Pellino2 RING mutant (RING) or
Pellino2 FHA mutant (FHA). Immunoblot analysis of myc and NLRP3 in lysates (Input) and IP myc samples from virus-infected BMDMs treated with 100
ng/ml LPS for indicated times. *p < 0.05 (paired, two-tailed Student’s t-test). Data are biological replicates that are representative of three independent
experiments (a-e, g-j) or mean ± s.e.m. of three independent experiments (f)
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demonstrate that Pellino2 can promote increased production of
mature bioactive IL-1β by facilitating activation of the NLRP3
inﬂammasome. This suggests that Pellino2 may favor the gen-
eration of a pro-inﬂammatory environment whereas
Pellino3 seems to temper the inﬂammatory response.
The involvement of Pellino2 in inﬂammasome activation
appears to be limited to NLRP3. Our data suggests that Pellino2
does not regulate caspase-11 expression or non-canonical
inﬂammasome activation in cells. Interestingly Pellino2 deﬁ-
ciency offers some protection in mice against the lethal effects of
LPS and yet such lethality has previously been attributed to
caspase-11-induced pyroptosis58. While caspase-11 cannot
directly cleave pro-IL-1β or pro-IL-18, it can promote indirect
formation of the NLRP3 inﬂammasome by Gasdermin D-
mediated membrane pore formation and pyroptosis. Thus,
caspase-11 can indirectly induce processing of the precursors of
both IL-1β and IL-1859. Such activation of NLRP3 may be
compromised in Pellino2-deﬁcient mice and underlie the reduced
serum levels of IL-1β and increased survival in response to in vivo
administered LPS. However lack of Pellino2 does not affect the
ability of transfected LPS, a means of activating non-canonical
inﬂammasome activation, to promote secretion of IL-1β from
BMDMs. The mechanism by which caspase-11 activates the
NLRP3 pathway remains to be fully delineated and the lack of
effect of Pellino2 deﬁciency on this non-canonical pathway may
reﬂect a different activating mechanism than the Pellino2-
dependent mechanism employed in the canonical NLRP3 path-
way that is triggered by LPS/ATP.
The mediatory role of Pellino2 in NLRP3 activation represents
a new mechanistic insight into the molecular basis by which this
inﬂammasome is activated. While Pellino2 is not a player in the
activation of NFκB and induction of pro-IL-1β and NLRP3, we
now propose a new regulatory pathway that involves Pellino2-
dependent ubiquitination of NLRP3. Previous reports have
described TRIM31, FBXL2, and MARCH7 to promote ubiquiti-
nation and degradation of NLRP324–26 with de-ubiquitination by
the BRCC3 complex facilitating activation of NLRP327–29. While
TRIM31, FBXL2, and MARCH7 are more associated with K48-
linked ubiquitination and degradation of NLRP3, we show that
NLRP3 is initially modiﬁed with K63-linked polyubiquitin chains,
in response to priming signals such as LPS. The loss of Pellino2-
dependent ubiquitination of NLRP3 leads to impaired inﬂam-
masome activation suggesting K63-linked ubiquitination of
NLRP3 to be an important part of the priming process. Indeed
MCC950, a highly potent and selective inhibitor of
NLRP3 strongly suppresses this priming-induced K63-linked
ubiquitination of NLRP3.
Having performed its role as part of the priming process, the
ubiquitin chains on NLRP3 presumably need to be removed by
BRCC3 to facilitate downstream inﬂammasome complex forma-
tion. While the molecular basis to the positive effects of Pellino2-
dependent ubiquitination remains to be delineated, it may facilitate
the transient recruitment of an accessory protein(s) that facilitates
NLRP3 activation or alternatively impair the binding of an inhibi-
tory protein such as IRAK1, as demonstrated in this study. While
our data clearly demonstrate that Pellino2 can promote ubiquiti-
nation of NLRP3, we were unable to show, using in vitro ubiqui-
tination assays, that NLRP3 is a direct substrate for Pellino2. This
suggests that the ubiquitination is mediated by another E3 ubiquitin
ligase or that the Pellino2-induced ubiquitination is dependent on
some ancillary protein or process that is triggered by the priming
signal. Our data also adds to a growing appreciation of the
importance of ubiquitination for the NLRP3 inﬂammasome and its
various constituents. Linear ubiquitination of ASC, by the LUBAC
component HOIL-1L, is required for NLRP3 inﬂammasome
assembly60 and polyubiquitination of pro-IL-1β facilitates its
interaction with caspase-161, a prologue to assembly of the NLRP3
complex61, 62. In addition, the E3 ligases cIAP1 and cIAP2 promote
K63-linked polyubiquitination of caspase-1, a pre-requisite for its
full activation63 whereas autophagy targets ubiquitinated pro-
caspase-1 and inﬂammasomes for degradation64.
Since we were unable to show that Pellino2 directly ubiquiti-
nates NLRP3, we explored the possibility that it could target an
intermediate protein to effect such ubiquitination. We have pre-
viously shown Pellino2 to interact with IRAK165 and the latter
can also associate with NLRP366, 67 and thus we explored the
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Fig. 9 Schematic representation of Pellino2 mediated NLRP3 inﬂammasome priming. In wild type macrophages LPS promotes the association of Pellino2
with NLRP3 and so facilitates ubiquitination of NLRP3. This promotes NLRP3 inﬂammasome assembly, ASC oligomerization and downstream caspase-1-
mediated processing of pro-IL-1β and pro-IL-18 and pyroptosis. Pellino2 also promotes ubiquitination of IRAK1 and so limits the interaction of IRAK1 with
NLRP3 and prevents the inhibitory effects of IRAK1 on NLRP3 activation. In Peli2−/− macrophages this braking effect of Pellino2 on IRAK1 is removed,
allowing for IRAK1 to interact with NLRP3 and suppress downstream activation of the NLRP3 inﬂammasome
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regulatory effects of Pellino2 on IRAK1. We now show that
Pellino2 mediates LPS-induced ubiquitination of IRAK1 that is
associated with impaired binding to NLRP3. Intriguingly we also
show that IRAK1 acts to negatively regulate the NLRP3 pathway
and this is consistent with reduced binding of Pellino2 to NLRP3
and ubiquitination of the latter. Thus, we now present a novel
network for regulating NLRP3 in which Pellino2 acts to promote
ubiquitination of NLRP3, an important part of the priming
process, and this is counter-regulated by IRAK1 that can bind to
NLRP3 to suppress its ubiquitination and activation. IRAK1
kinase activity appears to be very important for mediating these
effects since a kinase inactive form of IRAK1 strongly favors
ubiquitination of NLRP3. Interestingly, previous studies have
suggested a positive role for IRAK1 in acute NLRP3 activation
that is triggered by short co-treatment with LPS and ATP that is
independent of priming and new protein synthesis66, 67. However,
we now propose a negative role for IRAK1 in the priming phase
of NLRP3 activation and this is consistent with an earlier study
showing increased processing of caspase-1 in IRAK1 knockout
cells under these conditions67. The counter-regulatory roles of
Pellino2 and IRAK1 in this pathway highlights the close interplay
between the IRAK and Pellino families. Previous reports have
described IRAKs as being capable of phosphorylating Pellino
proteins to increase their E3 ubiquitin ligase activities. However,
it is highly unlikely that IRAK1-induced phosphorylation and
activation of Pellino2 is upstream of NLRP3 inﬂammasome
activation since we show enhanced interaction of Pellino2 with
NLRP3 and increased ubiquitination and activation of NLRP3 in
IRAK1-deﬁcient cells. Furthermore, in the context of LPS sig-
naling, IRAKs are not employed for this purpose and instead
TBK1/IKKε have been proposed to act as the activating kinases
for Pellino proteins38. Instead, we speculate that IRAK1 may
promote phosphorylation of NLRP3 to restrict recruitment of
Pellino2. Intriguingly, NLRP3 activation is negatively controlled
by phosphorylation of its pyrin domain68. While the effector
kinases were not identiﬁed in the latter report, our studies now
highlight the importance of IRAK1 as a negative regulator of
NLRP3 and as a lead candidate kinase that underlies the inhibi-
tory effects of NLRP3 phosphorylation. We also describe a new
regulatory network, involving an E3 ubiquitin ligase and a kinase,
that controls NLRP3 activation and ascribe the ﬁrst physiological
role to Pellino2. Such intricate control of this inﬂammasome
likely serves a crucial role in precluding dysregulated NLRP3
activation and uncontrolled inﬂammatory diseases. Future studies
on this pathway are warranted to provide a better understanding
of associated disease and to provide important clues for novel
interventive strategies.
Methods
Mice. Peli2−/− mice were generated by Taconic Artemis using proprietary tech-
nology. To generate constitutive Peli2−/−mice, mice that were heterozygous for the
targeted allele were bred with mice containing a Flpe transgene (C57BL/6-Tg
(CAG-Flpe)2Arte). This resulted in the deletion of exon 2–6 and loss of function of
the Peli2 gene. The Flpe transgene was removed by breeding the resulting Peli2+/−
mice with C57BL/6 mice during colony expansion. Mice were genotyped by PCR
analysis of DNA isolated from ear punches using primers “a,” GCCTCTA-
CAGGATGCTCATTT; “b,” GGACAGTCATGCTAGTCTGAGG; “c,”
GAGACTCTGGCTACTCATCC; and “d,” CCTTCAGCAAGAGCTGGGGAC.
Bone marrow from Irak1−/− mice were provided by Prof. Katherine Fitzgerald, the
University of Massachusetts Medical School. Genotype of mice was conﬁrmed by
western blot for IRAK1 in cultured BMDMs55. All animal experiments were per-
formed under licenses of the Health Products Regulatory Authority (HPRA) of
Ireland and the UK Home Ofﬁce with all protocols being approved by the Research
Ethics committees of Maynooth University or Queens University Belfast. Sample
sizes used are in line with other similar published studies. All animals were used at
age 8–12 weeks. Animals were allocated to experimental groups based on genotype,
age, and sex. No randomization methods were used. Mice were housed in indivi-
dually ventilated cages. Mice were culled using cervical dislocation in isolation from
any other mice.
Plasmids and reagents. The plasmids myc-tagged Pellino2, Pellino2-C335A/338A
(Peli2-RING), and Pellino2-T187A/N188A (Peli2-FHA) were generated in house;
V5-NLRP3 was donated by Prof. Jae Jung, the University of Southern California.
IRAK1 and FLAG-tagged IRAK4 were generated in house. HA-ubiquitin was from
Addgene. All antibodies were used at a dilution of 1:1000 unless otherwise stated.
Anti-p-ERK (9101), anti-ERK (9102), anti-p-IκBα (9246), anti-pIKK (14938), anti-
p65 (3033) anti-p-P38 (9211), anti-P38 (9212), anti-p-Jnk (9251), anti-Jnk (9252),
anti-myc (2276), anti-IRAK1 (4504), anti-IRAK4 (4363), and anti-human caspase
1 p20 (4199) were from CellSignaling; anti-mouse caspase1 p20 (AG-20B-0042-
C100) and anti-mouse NLRP3 (AG-20B-0014-C100) was from adipogen; anti-
mouse IL1β (AF-401-NA) was from R&D; anti-IκB-α (C-21; sc-371), anti-Ub
(P4D1; sc-8017), and anti-ASC (sc-514414) was from Santa Cruz; anti-HA (16B12;
MMS-101P) was from Covance; anti-K63 ubiquitin (HWA4C4; BML-PW0600)
was from Enzo life science; anti-K48 ubiquitin (Apu2; 05-1307) was from Milli-
pore; anti-ﬂag (F3165) and anti-β-actin (AC-15; A 1978) were from Sigma; anti-
mouse IRDyeTM 680 (926-68070) and anti-rabbit IRDyeTM 800 (926-32211) were
from LI-COR Biosciences; anti-mouse-HRP and anti-rabbit-HRP were from Pro-
mega. Anti-rabbit Alexa Fluor 568 (A-11011) was from Invitrogen. Adenosine 5′-
triphosphate disodium salt hydrate (ATP) (A1852) and Nigericin (N7143) were
from Sigma. LPS (ALX-581-010-L002) was from Enzo. Pam3CSK4, Pam2CSK4,
Zymosan, Poly (I:C), Flagellin, Clo75, Clo97, CpG, Alum, and Poly(dA:dT) were
from Invivogen. Murine IL-1β was from R&D. Cells were transfected using Lip-
fectamine 2000 (Invitrogen) according to the manufacturer’s instructions. LDH
cytotoxicity assay kit (61780) was from Promega.
Cell culture. HEK293T (ATCC CRL-11268) were cultured in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 10% (v/v) fetal bovine serum, 100 U/ml
penicillin and 100 μg/ml streptomycin. THP1 cells were cultured in RPMI-1640
medium supplemented with 10% (v/v) fetal bovine serum, 100 U/ml penicillin and
100 μg/ml streptomycin. All cell lines were obtained from the ATCC and have been
previously validated using the STR method by the ATCC. Cell lines were not tested
for mycoplasma contamination. For isolation of BMDMs, tibias and femurs were
removed from WT and Peli2−/− mice by sterile techniques and bone marrow was
ﬂushed with fresh RPMI-1640 plus GlutaMAX-I medium using a 271/4 gage needle.
Cells were plated in medium supplemented with 10% (v/v) conditioned medium of
L929 mouse ﬁbroblasts and were maintained for 6 days at 37 °C in a humidiﬁed
atmosphere of 5% CO2. Medium was replaced every 2 days. Peritoneal macro-
phages were harvested by injecting sterile PBS containing 10% (v/v) fetal bovine
serum (5 ml) into the peritoneal cavity. The peritoneal exudate was withdrawn and
centrifuged at 1500 g for 5 min. Pelleted peritoneal cells were resuspended in RPMI
containing 10% (v/v) fetal bovine serum and cultured at 37 °C prior to indicated
stimulations. Immortalized WT, Irak1−/−, and Irak4−/− BMDMs (iBMDMS) were
provided by Prof. Katherine Fitzgerald, the University of Massachusetts Medical
School. iBMDMs were cultured and passaged every 3 days in fresh RPMI-1640 plus
GlutaMAX-I medium.
ELISA. Primary BMDMs were seeded (1 × 106 cells per ml; 200 μl/well) in 96-well
plates and allowed to rest for 24 h. Cells were then stimulated with the indicated
ligands. Conditioned media was collected at the indicated time points and IL-1β,
IL-18, TNF, IL-6, RANTES, and CXCL1 were quantiﬁed by sandwich ELISA (R&D
Systems).
Cytotoxicity assay. Conditioned medium from treated BMDMs was assessed for
LDH release using the CytoTox96 non-radioactive cytotoxicity assay (Promega) as
per manufacturer’s instructions.
Inﬂammasome activation assays. Cells were primed with LPS (100 ng/ml) from
E. coli serotype EH100 (ra) TLRgrade for 3 h followed by stimulation with the
inﬂammasome activators: adenosine 5′-triphosphate disodium salt hydrate (ATP)
(5 mM) for 1 h, Poly (dA:dT) (1 μg/ml) transfected with Lipofectamine 2000
(Invitrogen) for 6 h or Nigericin (5 μM) for 1 h. For noncanonical inﬂammasome
activation, cells were primed with 100 ng/ml Pam3CSK4 (Invivogen) for 3 h, fol-
lowed by transfection of LPS (2 μg/ml) using Lipofectamine 2000 for 6 h or primed
with LPS for 3 h and stimulated with CTB (20 μg/ml) for 16 h.
Immunoblotting and immunoprecipitation. Primary BMDMs from WT and Peli2
−/−mice were cultured in 12-well plates (1 × 106 cells per ml; 1 ml) or 10 cm dishes
(2 × 106 cells per ml; 10 ml). HEK293T cells (2.5 × 105 cells per ml; 3 ml) were
grown in 6-well plates and where indicated were transfected with the appropriate
expression constructs. For whole cell lysate analysis, cells were lysed in NP-40 lysis
buffer (50 mM Tris-HCl, pH 7.4, containing 150 mM NaCl, 1% (w/v) IgePal, 50
mM NaF, 1 mM Na3VO4, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl
ﬂuoride and complete protease inhibitor mixture (Roche)). For co-immunopreci-
pitation, cells were treated as indicated and then collected in 200 μl 0.5 × NP-40
lysis buffer, followed by incubation for 30 min at 4 °C. Cell lysates were then
incubated with the appropriate antibody and an aliquot (50 μl) of protein
A–protein G–agarose was added to each sample, followed by incubation overnight
at 4 °C. Immunoprecipitates were collected by centrifugation for 1 min at 1000 g at
4 °C and the beads were then washed four times with 1 ml of NP-40 lysis buffer
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(without Na3VO4, dithiothreitol, phenylmethylsulfonyl ﬂuoride, or protease-
inhibitor “cocktail”). An aliquot (40 μl) of SDS-PAGE sample buffer (62.5 mM
TrisHCl, pH 6.8, 10% (w/v) glycerol, 2% (w/v) SDS, 0.7 M β-mercaptoethanol, and
0.001% (w/v) bromophenol blue) was added to the beads. Samples were resolved by
SDS-PAGE, transferred to nitrocellulose membranes and analyzed by immunoblot
with the following antibodies as appropriate: anti-NLRP3, anti-IRAK1, anti-myc,
and anti-FLAG. Immunoreactivity was visualized by the Odyssey Imaging System
(LICOR Biosciences) or enhanced chemiluminescence. For experiments assessing
the ubiquitination status of NLRP3 or IRAK1, cells were collected in 200 μl RIPA
buffer (25 mM Tris-HCL, 150 mM NaCl, 1% (w/v) IgePal, 1% (w/v) sodium
deoxycholate). Cell lysates were treated with 1% (w/v) SDS and heated to 95 °C for
5 min to dissociate NLRP3 or IRAK1 from any associated proteins. Lysates were
then diluted 10 fold in RIPA buffer before immunoprecipitation. Immunopreci-
pitated samples were analyzed by immunoblot with anti-ubiquitin (P4D1; sc-8017;
Santa Cruz). For immunoblotting of IL-1β and Caspase-1 in cell supernatants,
conditioned medium was collected and ﬁltered using ﬁlter spin columns to reduce
salt and remove abundant serum proteins. Filtrates were added to 4 × SDS-PAGE
sample buffer and resolved by SDS-PAGE for immunoblot analysis.
Tandem ubiquitin binding entity analysis. Primary BMDMs from WT and Peli2
−/− mice were cultured in 10 cm dishes (2 × 106 cells per ml; 10 ml). For enrich-
ment of ubiquitinated proteins, Ubq-TUBE-Agarose (UM-401) or K63-TUBE-
FLAG (UM-604) or K48-TUBE-FLAG (UM-605) (Life Sensors) were used
according to manufacturer instructions. Brieﬂy, cells were lysed in TUBE lysis
buffer (100 mM Tris HCL pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.5%
Triton) containing 1,10-phenanthroline (5 mM), PR-619 (100 μM) N-
Ethylmalamide (5 mM) and 20 μl of Ubq-TUBE agarose or 500 nM of K63-TUBE-
FLAG or K48-TUBE-FLAG. Cell lysates were then incubated for 1 h on ice to allow
TUBE binding. For enrichment of FLAG-tagged TUBEs, M2-FLAG afﬁnity gel
(A220, Sigma) was equilibrated in TBST for 5 min then added to samples (20 μl/
sample) and incubated at 4 °C for 2 h with rotation. TUBE-enriched FLAG afﬁnity
gel was then collected by centrifugation for 5 min at 5000 rpm at 4 °C and washed
three times with 1 ml of wash buffer (TUBE lysis buffer without Triton). An aliquot
(25 μl) of SDS-PAGE sample buffer (62.5 mM TrisHCl, pH 6.8, 10% (w/v) glycerol,
2% (w/v) SDS, 0.7 M β-mercaptoethanol and 0.001% (w/v) bromophenol blue) was
added to the beads. Samples were resolved by SDS-PAGE, transferred to nitro-
cellulose membranes and analyzed by immunoblot with the following antibodies as
appropriate: anti-NLRP3, anti-IRAK1, anti-K63-linked ubiquitin, anti-K48 linked
ubiquitin, and anti-ubiquitin. Immunoreactivity was visualized by the Odyssey
Imaging System (LICOR Biosciences).
Real time PCR analysis. Total RNA was extracted from tissues or cells using
Trizol (Invitrogen). cDNA was generated from 2 μg RNA using MMLV Reverse
Transcriptase (Bioscript Bioline) and real-time PCR analyses were performed with
SensiMix SYBR Master mix (Bioline) using an Applied Biosystems StepOnePlus™
Real-Time PCR System according to the manufacturer’s instructions. The abun-
dance of each mRNA was normalized relative to PCR of the housekeeping gene
Hypoxanthine-guanine phosphoribosyltransferase (Hprt). Mouse Il1β, forward,
CGGCACACCCACCCTG, and reverse, AAACCGTTTTTCCATCTTCTTCT;
mouse Il6, forward, ACAACCACGGCCTTCCCTAC, and reverse, TCCAC-
GATTTCCCAGAGAACA; The abundance of each mRNA was normalized relative
to PCR of the housekeeping gene Hprt with the following primers: forward,
GTCCCAGCGTCGTGATTAGC, and reverse, TGGCCTCCCATCTCCTTCA.
LPS septic shock model. Mice aged 8–12 weeks were administered LPS 20 mg/kg
by intraperitoneal injection. Serum was collected after 6 h and various cytokine
assayed by ELISA. For survival analysis, mice were administered LPS 50 mg/kg
intraperitoneally and monitored every 6 h for 72 h.
P. aeruginosa infection. Male WT and Peli2−/− mice were inoculated intraper-
itoneally with P. aeruginosa (PAO1 strain, kindly provided by Prof Scott Bell, the
University of Queensland) (100 µl; 1.5 × 107 CFU), suspended in sterile endotoxin-
free PBS, or sham inoculated with sterile endotoxin-free PBS. At 10 h post-
inoculation the animals were killed by cervical dislocation. Peritoneal lavage was
collected using 5 ml of ice cold endotoxin-free PBS, centrifuged at 1000 g for 10
min and the supernatants assayed for levels of IL-1β, IL-18, and IL-6. For cell-based
infections, bacteria were grown for 18 h at 37 °C in LB Broth. Bacteria were then
diluted 1/5 in LB broth and cultured for a further 2 h. Indicated cells were infected
at a multiplicity of infection (MOI) of 100:1 for 6 h. Cell supernatants and lysates
were then collected for ELISA and western blot analysis.
ASC oligomerization and ﬂuorescence microscopy. ASC oligomers were ana-
lyzed as previously described54. Cells were thus treated with LPS with or without
ATP or Nigericin for the indicated times. Cells were then washed in PBS and lysed
in NP-40 buffer on ice. NP-40 soluble fractions were retained and insoluble pellets
were washed twice in PBS. Insoluble pellets were then reconstituted in PBS and
cross-linked in 2 mM Suberic acid for 1 h at room temperature with gentle agita-
tion. Cross-linked pellets were washed twice in PBS and lysed in 2 × sample buffer
for western blot analysis of ASC oligomers. Coverslips were coated with BMDMs
for ﬂuorescence microscopic analysis of ASC specks. Cell were ﬁxed for 5 min with
methanol (−20 °C) and washed three times with PBS. Samples were incubated with
anti-rabbit ASC (1:200) overnight, followed by incubation with anti-rabbit Alexa
Fluor 568 (5 μg/ml) and mounting in DAPI-containing media. Images were cap-
tured using the ×20 objective of a ﬂuorescent microscope. Image analysis was
performed using Olympus cellSens Dimension 1.9 software
Mitochondrial ROS. Primary BMDMs were treated as indicated and assayed for
mROS production using Mitosox (LifeTechnologies) according to the manu-
facturer’s instructions. Brieﬂy, cells were washed twice in PBS and then incubated
with 2.5 mM Mitosox in PBS for 15 min at 37 °C. Cells were then washed twice in
cold PBS (1 ml) followed by ﬂow cytometric analysis of Mitosox-reactive cells using
an AcuriC6 ﬂow cytometer and Flowjo software
Preparation and transfection of siRNA. Human Pellino2-speciﬁc siRNAs were
from the LifeTechnologies (AM16708, 133379). siRNA was delivered to THP1 cells
via transfection with Lipfectamine2000 according to the manufacturer's instruc-
tions and allowed to recover for 48 h prior to experiments.
Retroviral rescue assay. Myc-tagged murine Pellino2 (mPeli2), Pellino2-C337A/
334A (mPeli2-RING), and Pellino2-R106A/R136A (mPel2-FHA) were sub-cloned
into the retroviral MSCV2.2-IRES-GFP vector. The empty MSCV vector (as con-
trol) or MSCV containing the indicated Pellino2 construct (10 μg) was co-
transfected with the packaging vector ψ (5 μg) and VSV-g envelope vector (5 μg)
into a T75 cm2 ﬂask of HEK293T cells in DMEM medium (10ml). After 48 h, the
retrovirus-containing medium was collected. WT and Pellino2-deﬁcient BMDMs
were then plated with virus containing medium (ratio of 1:1 (v:v)) in 12-well plates
for ELISA/cell lysate analysis or 10 cm2 dishes for co-immunoprecipitation analysis.
Retrovirus-infected cells were incubated at 37 °C for 24 h prior to experiments.
Densitometry analysis. Densitometry analysis was performed using Licor Odys-
sey and Gel QUANT software.
Statistical analysis. Student’s t-test and two-way Mantel-Cox were used, where
appropriate, for statistical analysis. 3–12 mice were used per experiment, sufﬁcient
to calculate statistical signiﬁcance and in line with similar studies published in the
literature. No animals or samples were excluded from the analysis
Data availability. All source data is available upon request.
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